The PE Ratio as of November 2024 (TTM) for U.S. Stem Cell, Inc. (USRM) is -0.01

According to U.S. Stem Cell, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -97.02% compared to the average of -0.34 of the last 4 quarters.

U.S. Stem Cell, Inc. (USRM) Historical PE Ratio (quarterly & annually)

How has USRM PE Ratio performed in the past?

The mean historical PE Ratio of U.S. Stem Cell, Inc. over the last ten years is -1.22. The current -0.01 PE Ratio has changed -18.03% with respect to the historical average. Over the past ten years (40 quarters), USRM's PE Ratio was at its highest in in the December 2017 quarter at 7.15. The PE Ratio was at its lowest in in the March 2018 quarter at -49.45.

U.S. Stem Cell, Inc. (USRM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of U.S. Stem Cell, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

U.S. Stem Cell, Inc. (USRM) Average PE Ratio

How has USRM PE Ratio performed in the past?

The current PE Ratio of U.S. Stem Cell, Inc. (USRM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

U.S. Stem Cell, Inc. (USRM) PE Ratio vs. Peers

How is USRM’s PE Ratio compared to its peers?

U.S. Stem Cell, Inc.’s PE Ratio is less than Adhera Therapeutics, Inc. (-0.00), greater than AgeX Therapeutics, Inc. (-1.48), greater than XOMA Corporation (-19.71), greater than Lineage Cell Therapeutics, Inc. (-6.55), greater than Nascent Biotech, Inc. (-4.88), greater than ProtoKinetix, Incorporated (-10.32), greater than RespireRx Pharmaceuticals Inc. (-0.49), greater than Silo Pharma, Inc. (-0.92), greater than VG Life Sciences Inc. (-20.33), greater than PharmaTher Holdings Ltd. (-6.78), greater than Regen BioPharma, Inc. (-0.73), greater than Regen BioPharma, Inc. (-1.89), greater than Mymetics Corporation (-0.03), less than Theralink Technologies, Inc. (0.03), less than GB Sciences, Inc. (0), greater than SciSparc Ltd. (-0.06), greater than null (-0.02),

Build a custom stock screener for U.S. Stem Cell, Inc. (USRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like U.S. Stem Cell, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

U.S. Stem Cell, Inc. (USRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like U.S. Stem Cell, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.